undamentalytics Newsletter

National Healthcare Corp insider trading

Every open-market purchase and sale by National Healthcare Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
National Healthcare Corp insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following National Healthcare Corp’s insiders pay?

From January 19, 2010 to September 23, 2026, 22 insiders reported 15 open-market purchases and 189 sales not made under a pre-set plan in National Healthcare Corp. Twelve months after each purchase was reported, the shares were +25.1% against the S&P 500 on average (median +17.2%), over 14 purchases with a full year of prices; 79% beat the index. After sales, the shares moved −0.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 17, 2010 into $64,764 by November 2, 2026, +12.0% a year. It held shares 32% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $35,641 (+8.0% a year), and held throughout $88,810 (+14.2%).

$0$25.0k$50.0k$75.0k 201020122014201620182020202220242026 $88.8k$64.8k$35.6k
Copying National Healthcare Corp's insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by National Healthcare Corp's insiders from May 17, 2010, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 32% of the time.
National Healthcare Corp: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Abernathy James Paul Director 1 +53.2% (1) 100% 38 −2.4% (38) August 15, 2024
Tucker Lawrence C Director 0 — — 36 +18.3% (36) August 10, 2010
Hassan Emil E Director 0 — — 30 −4.6% (26) June 23, 2026
Powell Julia W Sr.VP - Patient Services 0 — — 23 −10.2% (23) February 28, 2017
Lassiter David L Sr. Vice President, Corp. Aff. 1 +0.9% (1) 100% 18 −3.0% (18) September 20, 2016
Burgess Ernest G III Director 1 +43.7% (1) 100% 13 −9.0% (13) May 17, 2023
Laroche Richard F Jr Director 5 +10.8% (5) 40% 4 −7.8% (3) May 22, 2026
Flatt Stephen Fowler CEO 0 — — 5 −8.9% (3) August 20, 2026
National Health Corp Other 0 — — 5 −0.1% (5) January 3, 2025
Adams Robert G CEO 3 +34.3% (3) 100% 0 — September 7, 2023
Shelly Timothy J. Sr.VP Operations 0 — — 3 +13.4% (1) May 20, 2026
Smith Jeffrey Russell SVP & Treasurer 0 — — 3 +2.4% (3) November 30, 2017
Ussery Robert Michael President & COO 1 +17.9% (1) 100% 2 −22.2% (2) December 17, 2019
Adams W Andrew Director 2 +39.5% (2) 100% 0 — August 10, 2023
Kidd Brian F SVP, CFO 0 — — 2 −32.3% (1) September 14, 2026
Lines John K Senior VP & General Counsel 0 — — 2 −2.8% (2) September 5, 2018
Coggin D Gerald Sr. V.P., Corp Relations 0 — — 1 +16.5% (1) May 14, 2010
Dodson Vicki L Sr.VP Patient Srvcs 0 — — 1 — September 23, 2026
Flatt Ben Anderson Sr Senior VP & CIO 0 — — 1 — September 2, 2026
Gifford David R. Director 0 — — 1 — August 28, 2026
Mccreary Josh A Senior VP & General Counsel 0 — — 1 — September 14, 2026
Piercey Lisa Director 1 — — 0 — June 2, 2026

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded National Healthcare Corp

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of National Healthcare Corp in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +36.5% against the index. After 14 selling crowds, −0.2%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
June 30, 20263 selling+3.5%not yetnot yet
December 31, 20253 selling+22.8%+49.0%not yet
September 30, 20243 selling−17.0%−23.6%−18.9%
July 31, 20232 buying+23.0%+56.4%+115.1%
January 31, 20193 selling−14.5%−1.6%−14.3%
August 31, 20183 selling+13.6%+4.3%+1.2%
February 28, 20173 selling−10.0%−21.5%−36.2%
June 30, 20153 selling+1.4%−3.5%−2.8%
August 29, 20143 selling+2.1%+6.6%+7.4%
March 31, 20143 selling−3.6%−4.1%+4.3%
November 29, 20134 selling−7.0%−11.2%−6.1%
September 30, 20133 selling+3.4%+8.8%+0.7%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Latest 12 of 17. Total returns from the month end; past patterns are not a forecast.

← Back to National Healthcare Corp · Funds · Politicians